uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker: Comparison with other radioiodination methods
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences.
Show others and affiliations
2003 (English)In: Bioconjugate chemistry, ISSN 1043-1802, Vol. 14, no 4, 805-10 p.Article in journal (Refereed) Published
Abstract [en]

We have evaluated the applicability of the [(4-isothiocyanatobenzylammonio)undecahydro-closo-dodecaborate (1-)] (DABI) linker molecule for antibody radiohalogenation and compared it to radiohalogenation using the linker N-succinimidyl 4-iodobenzoate (PIB) and to direct radiohalogenation using Chloramine T. These studies were performed to assess the potential of DABI conjugates and to optimize the biological properties of halogen-labeled cMAb U36. The three conjugates were evaluated in vitro for their specificity and affinity and in vivo for their biodistribution patterns in normal mice at 1.5, 6, 24, and 96 h pi. Labeling efficiencies of direct CAT labeling, indirect PIB labeling, and indirect DABI labeling were 90-95%, 60%, and 68%, respectively. This resulted in a PIB:cMAb U36 molar ratio of 1.8-2.5 and a DABI:cMAb U36 molar ratio of 4.1. The in vitro data demonstrated specific binding for all conjugates and similar affinities with values around 1 x 10(8) M(-)(1). However, the in vivo data revealed accumulation of the radioiodine uptake in thyroid for the directly labeled conjugate, with a value 10 times higher than the indirectly labeled conjugates 96 h pi. Both the (125)I-PIB-cMAb U36 and (125)I-DABI-cMAb U36 conjugates yielded a low thyroid uptake with no accumulation, indicating different catabolites for these conjugates. This may favor the use of the indirectly labeled conjugates for future studies. Apart from the specific results obtained, these findings also demonstrate how the right linker molecule will provide additional opportunities to further improve the properties of an antibody-radionuclide conjugate.

Place, publisher, year, edition, pages
2003. Vol. 14, no 4, 805-10 p.
Keyword [en]
Animals, Antibodies; Monoclonal/administration & dosage/*chemistry/pharmacokinetics, Benzoates/chemistry/pharmacokinetics, Boron Compounds/*chemistry/pharmacokinetics, Cell Line; Tumor/radiation effects, Chloramines/chemistry/pharmacokinetics, Comparative Study, In Vitro, Iodine Radioisotopes/*chemistry/pharmacokinetics, Mice, Molecular Structure, Radiopharmaceuticals/*chemistry/pharmacokinetics, Research Support; Non-U.S. Gov't, Staining and Labeling/methods, Time Factors, Tissue Distribution
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-72824DOI: 10.1021/bc034003nPubMedID: 12862434OAI: oai:DiVA.org:uu-72824DiVA: diva2:100735
Available from: 2007-05-04 Created: 2007-05-04 Last updated: 2009-12-10Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12862434&dopt=Citation

Search in DiVA

By author/editor
Nestor, MarikaPersson, MikaelTolmachev, VladimirAnniko, Matti
By organisation
Department of Surgical Sciences
In the same journal
Bioconjugate chemistry
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 261 hits
ReferencesLink to record
Permanent link

Direct link